Activity of α- and θ-defensins against primary isolates of HIV-1

Journal of Immunology

Volumn 173, Issue 1, 2004, Pages 515-520

  Wang, Wei ^a   Owen, Sherry M ^b   Rudolph, Donna L ^b   Cole, Alexander M ^a   Hong, Teresa ^a   Waring, Alan J ^a   Lal, Renu B ^b   Lehrer, Robert I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; DEFENSIN; DEFENSIN 1; DEFENSIN 2; DEFENSIN 3; GLYCOPROTEIN GP 120; HUMAN NEUTROPHIL PEPTIDE 4; LECTIN; RETROCYCLIN 1; RETROCYCLIN 2; RETROCYCLIN 3; THETA DEFENSIN; THETA DEFENSIN 1; THETA DEFENSIN 2; THETA DEFENSIN 3; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ANTIVIRAL ACTIVITY; ARTICLE; BINDING AFFINITY; CELL LINE; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; HOMINID; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; VIRUS ISOLATION;

EID: 2942729771     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.1.515     Document Type: Article

References (44)

1. Ganz, T. 2001. Antimicrobial proteins and peptides in host defense. Semin. Respir. Infect. 16:4.
2. Lehrer, R. I., and T. Ganz. 2002. Cathelicidins: a family of endogenous antimicrobial peptides. Curr. Opin. Hematol. 9:18.
3. Lehrer, R. I., and T. Ganz. 2002. Defensins of vertebrate animals. Curr. Opin. Immunol. 14:96.
4. Zhao, C., T. Nguyen, L. Liu, R. E. Sacco, K. A. Brogden, and R. I. Lehrer. 2001. Gallinacin-3, an inducible epithelial β-defensin in the chicken. Infect. Immun. 69:2684.
5. Leonova, L., V. N. Kokryakov, G. Aleshina, T. Hong, T. Nguyen, C. Zhao, A. J. Waring, and R. I. Lehrer. 2001. Circular minidefensins and posttranslational generation of molecular diversity. J. Leukocyte Biol. 70:461.
6. Tang, Y. Q., J. Yuan, G. Osapay, K. Osapay, D. Tran, C. J. Miller, A. J. Ouellette, and M. E. Selsted. 1999. A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated α-defensins. Science 286:498.
7. Tran, D., P. A. Tran, Y. Q. Tang, J. Yuan, T. Cole, and M. E. Selsted. 2002. Homodimeric θ-defensins from rhesus macaque leukocytes: isolation, synthesis, antimicrobial activities, and bacterial binding properties of the cyclic peptides. J. Biol. Chem. 277:3079.
8. Daher, K. A., M. E. Selsted, and R. I. Lehrer. 1986. Direct inactivation of viruses by human granulocyte defensins. J. Virol. 60:1068.
9. Lehrer, R. I., K. Daher, T. Ganz, and M. E. Selsted. 1985. Direct inactivation of viruses by MCP-1 and MCP-2, natural peptide antibiotics from rabbit leukocytes. J. Virol. 54:467.
10. Bastian, A., and H. Schafer. 2001. Human α-defensin-1 (HNP-1) inhibits adenoviral infection in vitro. Regul. Pept. 101:157.
11. Gropp, R., M. Frye, T. O. Wagner, and J. Bargon. 1999. Epithelial defensins impair adenoviral infection: implication for adenovirus-mediated gene therapy. Hum. Gene Ther. 10:957.
12. Chang, T. L., F. Francois, A. Mosoian, and M. E. Klotman. 2003. CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from α-defensin-1 HIV inhibition. J. Virol. 77:6777.
13. Mackewicz, C. E., J. Yuan, P. Tran, L. Diaz, E. Mack, M. E. Selsted, and J. A. Levy. 2003. α-Defensins can have anti-HIV activity but are not CD8 cell anti-HIV factors. AIDS 17:F23.
14. Zhang, L., W. Yu, T. He, J. Yu, R. E. Caffrey, E. A. Dalmasso, S. Fu, T. Pham, J. Mei, J. J. Ho, et al. 2002. Contribution of human α-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science 298:995.
15. Cohen, J. 2002. AIDS research: mystery anti-HIV factor unmasked? Science 297:2188.
16. Zhang, L., P. Lopez, T. He, W. Yu, and D. D. Ho. 2004. Retraction of an interpretation. Science 303:467.
17. Nguyen, T. X., A. M. Cole, and R. I. Lehrer. 2003. Evolution of primate θ defensins: a serpentine path to a sweet tooth. Peptides 24:1647.
18. Cole, A. M., T. Hong, L. M. Boo, T. Nguyen, C. Zhao, G. Bristol, J. A. Zack, A. J. Waring, O. O. Yang, and R. I. Lehrer. 2002. Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1. Proc. Natl. Acad. Sci. USA 99:1813.
19. Wang, W., A. M. Cole, T. Hong, A. J. Waring, and R. I. Lehrer. 2003. Retrocyclin, an antiretroviral θ-defensin, is a lectin. J. Immunol. 170:4708.
20. Munk, C., G. Wei, O. O. Yang, A. J. Waring, W. Wang, T. Hong, R. I. Lehrer, N. R. Landau, and A. M. Cole. 2003. The θ-defensin, retrocyclin, inhibits HIV-1 entry. AIDS Res. Hum. Retroviruses 19:875.
21. Gabius, H. J., S. Andre, H. Kaltner, and H. C. Siebert. 2002. The sugar code: functional lectinomics. Biochim. Biophys. Acta. 1572:165.
22. Crocker, P. R. 2002. Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling. Curr. Opin. Struct. Biol. 12:609.
23. Holmskov, U., S. Thiel, and J. C. Jensenius. 2003. Collections and ficolins: humoral lectins of the innate immune defense. Annu. Rev. Immunol. 21:547.
24. van Kooyk, Y., and T. B. Geijtenbeek. 2003. DC-SIGN: escape mechanism for pathogens. Nat. Rev. Immunol. 3:697.
25. Xiao, L., S. M. Owen, I. Goldman, A. A. Lal, J. J. deJong, J. Goudsmit, and R. B. Lal. 1998. CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCCR-5 usage. Virology 240:83.
26. Harwig, S. S., A. S. Park, and R. I. Lehrer. 1992. Characterization of defensin precursors in mature human neutrophils. Blood 79:1532.
27. Derdeyn, C. A., J. M. Decker, J. N. Sfakianos, X. Wu, W. A. O'Brien, L. Ratner, J. C. Kappes, G. M. Shaw, and E. Hunter. 2000. Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J. Virol. 74:8358.
28. Konopka, K., L. Stamatatos, C. E. Larsen, B. R. Davis, and N. Duzgunes. 1991. Enhancement of human immunodeficiency virus type 1 infection by cationic liposomes: the role of CD4, serum, and liposome-cell interactions. J. Gen. Virol. 72(Pt. 11):2685.
29. 2- macroglobulin is a principal defensin-binding protein. Am. J. Respir. Cell Mol. Biol. 5:101.
30. Panyutich, A. V., P. S. Hiemstra, S. van Wetering, and T. Ganz. 1995. Human neutrophil defensin and serpins form complexes and inactivate each other. Am. J. Respir. Cell Mol. Biol. 12:351.
31. 1 complement. FEBS Lett. 356:169.
32. Moutouh, L., J. Estaquier, D. D. Richman, and J. Corbeil. 1998. Molecular and cellular analysis of human immunodeficiency virus-induced apoptosis in lymphoblastoid T-cell-line-expressing wild-type and mutated CD4 receptors. J. Virol. 72:8061.
33. Poignard, P., E. O. Saphire, P. W. Parren, and D. R. Burton. 2001. gp120: biologic aspects of structural features. Annu. Rev. Immunol. 19:253.
34. Trkola, A., M. Purtscher, T. Muster, C. Ballaun, A. Buchacher, N. Sullivan, K. Srinivasan, J. Sodroski, J. P. Moore, and H. Katinger. 1996. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J. Virol. 70:1100.
35. Scanlan, C. N., R. Pantophlet, M. R. Wormald, S. E. Ollmann, R. Stanfield, I. A. Wilson, H. Katinger, R. A. Dwek, P. M. Rudd, and D. R. Burton. 2002. The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of α1→2 mannose residues on the outer face of gp120. J. Virol. 76:7306.
36. Kuschert, G. S., F. Coulin, C. A. Power, A. E. Proudfoot, R. E. Hubbard, A. J. Hoogewerf, and T. N. Wells. 1999. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry 38:12959.
37. Panyutich, A. V., E. A. Panyutich, V. A. Krapivin, E. A. Baturevich, and T. Ganz. 1993. Plasma defensin concentrations are elevated in patients with septicemia or bacterial meningitis. J. Lab. Clin. Med. 122:202.
38. Panyutich, A. V., N. N. Voitenok, R. I. Lehrer, and T. Ganz. 1991. An enzyme immunoassay for human defensins. J. Immunol. Methods 141:149.
39. Le, D. T., P. Borgs, T. W. Toneff, M. H. Witte, and S. I. Rapaport. 1998. Hemostatic factors in rabbit limb lymph: relationship to mechanisms regulating extravascular coagulation. Am. J. Physiol. 274:H769.
40. Ganz, T. 2003. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3:710.
41. Bevins, C. L. 1994. Antimicrobial peptides as agents of mucosal immunity. Ciba Found. Symp. 186:250.
42. Huttner, K. M., and C. L. Bevins. 1999. Antimicrobial peptides as mediators of epithelial host defense. Pediatr. Res. 45:785.
43. Quinones-Mateu, M. E., M. M. Lederman, Z. Feng, B. Chakraborty, J. Weber, H. R. Rangel, M. L. Marotta, M. Mirza, B. Jiang, P. Kiser, et al. 2003. Human epithelial β-defensins 2 and 3 inhibit HIV-1 replication. AIDS 17:F39.
44. Hein, M., E. V. Valore, R. B. Helmig, N. Uldbjerg, and T. Ganz. 2002. Antimicrobial factors in the cervical mucus plug. Am. J. Obstet. Gynecol. 187:137.